Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 53

Related Articles by Review for PubMed (Select 11529281)

1.

The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics.

Solèr M, Matz J, Townley R, Buhl R, O'Brien J, Fox H, Thirlwell J, Gupta N, Della Cioppa G.

Eur Respir J. 2001 Aug;18(2):254-61. Erratum in: Eur Respir J 2001 Oct;18(4):739-40.

2.

Omalizumab for asthma in adults and children.

Normansell R, Walker S, Milan SJ, Walters EH, Nair P.

Cochrane Database Syst Rev. 2014 Jan 13;1:CD003559. doi: 10.1002/14651858.CD003559.pub4. Review.

PMID:
24414989
3.

Spotlight on omalizumab in allergic asthma.

Bang LM, Plosker GL.

BioDrugs. 2004;18(6):415-8. Review.

PMID:
15571425
4.

Omalizumab: a review of its use in the management of allergic asthma.

Bang LM, Plosker GL.

Treat Respir Med. 2004;3(3):183-99. Review.

PMID:
15219177
5.

Anti-IgE for chronic asthma in adults and children.

Walker S, Monteil M, Phelan K, Lasserson TJ, Walters EH.

Cochrane Database Syst Rev. 2004;(3):CD003559. Review. Update in: Cochrane Database Syst Rev. 2006;(2):CD003559.

PMID:
15266491
6.

Anti-IgE for chronic asthma in adults and children.

Walker S, Monteil M, Phelan K, Lasserson TJ, Walters EH.

Cochrane Database Syst Rev. 2006 Apr 19;(2):CD003559. Review. Update in: Cochrane Database Syst Rev. 2014;1:CD003559.

PMID:
16625585
7.

A recombinant humanized anti-IgE monoclonal antibody (omalizumab) in the therapy of moderate-to-severe allergic asthma.

D'Amato G, Piccolo A, Salzillo A, Noschese P, D'Amato M, Liccardi G.

Recent Pat Inflamm Allergy Drug Discov. 2007 Nov;1(3):225-31. Review.

PMID:
19075985
8.

[Anti IgE antibodies for the treatment of difficult asthma].

Humbert M, Tonnel AB.

Rev Mal Respir. 2005 Dec;22(6 Pt 1):983-90. Review. French.

PMID:
16222222
9.

Omalizumab for the treatment of severe persistent allergic asthma in children aged 6-11 years: a NICE single technology appraisal.

Burch J, Griffin S, McKenna C, Walker S, Paton J, Wright K, Woolacott N.

Pharmacoeconomics. 2012 Nov 1;30(11):991-1004. doi: 10.2165/11597160-000000000-00000. Review.

PMID:
22950547
10.

Anti-IgE for chronic asthma.

Walker S, Monteil M, Phelan K, Lasserson TJ, Walters EH.

Cochrane Database Syst Rev. 2003;(3):CD003559. Review. Update in: Cochrane Database Syst Rev. 2004;(3):CD003559.

PMID:
12917972
11.

The role of omalizumab in the treatment of severe allergic asthma.

Chapman KR, Cartier A, Hébert J, McIvor RA, Schellenberg RR.

Can Respir J. 2006 Jul-Aug;13 Suppl B:1B-9B. Review.

12.

Anti-IgE therapy with omalizumab in asthma and allergic rhinitis.

Dodig S, Richter D, Cepelak I, Benko B.

Acta Pharm. 2005 Jun;55(2):123-38. Review.

PMID:
16179127
13.

Omalizumab in the treatment of severe asthma: efficacy and current problems.

Pelaia G, Renda T, Romeo P, Busceti MT, Maselli R.

Ther Adv Respir Dis. 2008 Dec;2(6):409-21. doi: 10.1177/1753465808100431. Review.

PMID:
19124386
14.

Anti-IgE antibodies for the treatment of asthma.

Buhl R.

Curr Opin Pulm Med. 2005 Jan;11(1):27-34. Review.

PMID:
15591885
15.

Does anti-IgE therapy help in asthma? Efficacy and controversies.

Avila PC.

Annu Rev Med. 2007;58:185-203. Review.

PMID:
17059361
16.

Omalizumab: a review of its use in the treatment of allergic asthma.

Plosker GL, Keam SJ.

BioDrugs. 2008;22(3):189-204. Review.

PMID:
18481901
17.

Omalizumab: a recombinant humanized anti-IgE antibody for allergic asthma.

Ruffin CG, Busch BE.

Am J Health Syst Pharm. 2004 Jul 15;61(14):1449-59. Review.

PMID:
15332692
18.

Anti-immunoglobulin E therapy with omalizumab for asthma.

Hendeles L, Sorkness CA.

Ann Pharmacother. 2007 Sep;41(9):1397-410. Epub 2007 Aug 14. Review.

PMID:
17698897
19.

The use of omalizumab in the treatment of severe allergic asthma: A clinical experience update.

Holgate S, Buhl R, Bousquet J, Smith N, Panahloo Z, Jimenez P.

Respir Med. 2009 Aug;103(8):1098-113. doi: 10.1016/j.rmed.2009.03.008. Epub 2009 Apr 10. Review. Erratum in: Respir Med. 2010 Jun;104(6):924.

20.

Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy.

Holgate ST, Djukanović R, Casale T, Bousquet J.

Clin Exp Allergy. 2005 Apr;35(4):408-16. Review.

PMID:
15836747
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk